Lantern Pharma’s Remarkable Phase 2 Trial Update in Advanced Lung Cancer
Lantern Pharma’s ongoing HARMONICâ„¢ clinical trial has yielded promising early results. The trial examines the efficacy of LP-300, a...
Jon Napitupulu
COYA Therapeutics’ Novel Patent Filing: Expanding Pipeline in Alzheimer’s Disease
COYA 301, a recombinant human low-dose interleukin-2 (LD IL-2), and Glucagon-Like Peptide-1 receptor agonists (GLP-1 RAs) have demonstrated potential...
SanBio Wins Approval for Akuugo as Chronic TBI Treatment
SanBio Co. Ltd has received approval in Japan for “AKUUGO® Suspension for Intracranial Implantation,” a groundbreaking cell-based therapy for...
Jemperli Expands Approval to All Adult Endometrial Cancer Patients
The FDA has granted approval for Jemperli (dostarlimab-gxly) in combination with chemotherapy (carboplatin and paclitaxel) followed by Jemperli alone...
AI-Empowered Immunotherapy Partnership: A Transformative Leap in Cancer Care
BostonGene and Takeda collaborate on research studies focused on immuno-oncology. Their partnership aims to enhance clinical trial design, improve...
Unlearn’s AI-Powered Clinical Trials with AbbVie and Johnson & Johnson
Unlearn, an AI company, showcased the impact of its technology in two poster sessions at the Alzheimer’s Association International...
New Study: Alzheimer’s Progression Explored with Revolutionary Cell Platform
Groundbreaking research has led to a novel model using human induced pluripotent stem cell (iPSC)-derived cortical neurons to understand...
Evolus Obtains Approval For Botox in Australia
Evolus, a performance beauty company focused on aesthetics, has launched operations in Australia by introducing Nuceiva (prabotulinumtoxinA). This marks...
BioAge Announces Groundbreaking Obesity Treatment Trial
BioAge Labs has initiated a Phase 2 clinical trial, STRIDES, to assess the efficacy of azelaprag, a small molecule...
Venetoclax and Fixed-Duration Calquence® Significantly Improve Leukemia Survival
An interim analysis of the AMPLIFY Phase III trial has revealed encouraging results in the treatment of chronic lymphocytic...